| Preparation and cytotoxic evaluation of PGV-1 derivative, CCA-1.1, as a new curcumin analog with improved-physicochemical and pharmacological properties RY Utomo, F Wulandari, D Novitasari, B Lestari, RA Susidarti, RI Jenie, ... Advanced Pharmaceutical Bulletin 12 (3), 603, 2022 | 16 | 2022 |
| CCA-1.1, a novel curcumin analog, exerts cytotoxic anti-migratory activity toward TNBC and HER2-enriched breast cancer cells D Novitasari, RI Jenie, RY Utomo, J Kato, E Meiyanto Asian Pacific Journal of Cancer Prevention: APJCP 22 (6), 1827, 2021 | 15 | 2021 |
| Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1 D Novitasari, RI Jenie, F Wulandari, RY Utomo, DDP Putri, J Kato, ... Research Journal of Pharmacy and Technology 14 (8), 4375-4382, 2021 | 15 | 2021 |
| New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells F Wulandari, D Novitasari, M Kirihata, J Kato, E Meiyanto Indonesian Journal of Pharmacy, 2020 | 15 | 2020 |
| The anti-migratory activity of a new curcumin analog, CCA-1.1, against T47D breast cancer cells F Wulandari, RY Utomo, D Novitasari, M Ikawati, M Kirihata, J Kato, ... International Journal of Pharmaceutical Research 13 (1), 1-11, 2021 | 11 | 2021 |
| A new curcumin analog, CCA-1.1, induces cell cycle arrest and senescence toward ER-positive breast cancer cells D Novitasari, F Wulandari, RI Jenie, J Kato, E Meiyanto International Journal of Pharmaceutical Research 13 (1), 1-9, 2021 | 11 | 2021 |
| The integrative bioinformatic analysis deciphers the predicted molecular target gene and pathway from curcumin derivative CCA-1.1 against triple-negative breast cancer (TNBC) D Novitasari, RI Jenie, J Kato, E Meiyanto Journal of the Egyptian National Cancer Institute 33, 1-10, 2021 | 10 | 2021 |
| Synthesis of new boron containing compound (CCB-2) based on curcumin structure and its cytotoxic effect against cancer cells E Meiyanto, RA Susidarti, RI Jenie, RY Utomo, D Novitasari, F Wulandari, ... Journal of Applied Pharmaceutical Sciences 10 (2), 60-66, 2020 | 10 | 2020 |
| Bioinformatic and molecular interaction studies uncover that CCA-1.1 and PGV-1 differentially target mitotic regulatory protein and have a synergistic effect against leukemia cells E Meiyanto, D Novitasari, RY Utomo, RA Susidarti, DDP Putri, J Kato Indonesian Journal of Pharmacy, 225–233-225–233, 2022 | 7 | 2022 |
| Estrogenic activity of ethanolic extract of papaya peels (Carica Papaya L.) on uterine weight and mammae gland proliferation on ovariectomy rats D Novitasari, DH Triutomo, FH Arifah, A Ivanawati, Z Ulum, R Murwanti Indonesian Journal of Cancer Chemoprevention 9 (2), 86-91, 2018 | 7 | 2018 |
| Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells D Novitasari, RI Jenie, J Kato, E Meiyanto Research in Pharmaceutical Sciences 18 (4), 358-370, 2023 | 5 | 2023 |
| Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer RY Utomo, F Wulandari, D Novitasari, RA Susidarti, M Kirihata, ... Journal of Advanced Pharmaceutical Technology & Research 13 (1), 70-76, 2022 | 5 | 2022 |
| Ethanolic extract of hedyotis corymbosa L. inhibits migration and MMP-9 activity on metastatic breast cancer cells D Novitasari, S Handayani, RI Jenie Indonesian Journal of Cancer Chemoprevention 9 (1), 16-22, 2018 | 5 | 2018 |
| Antimigratory evaluation from curcumin-derived synthetic compounds PGV-1 and CCA-1.1 on HCC1954 and MDA-MB-231 cells D Novitasari, E Meiyanto, J Kato, RI Jenie Indonesian Journal of Cancer Chemoprevention 13 (2), 71-82, 2022 | 4 | 2022 |
| Evaluation of the genotoxicity of three food additives using CHO-K1 Cells under in vitro micronucleus flow cytometry assay B Lestari, D Novitasari, H Putri, S Haryanti, E Sasmito, E Meiyanto Indonesian Journal of Cancer Chemoprevention 8 (2), 74-80, 2017 | 4 | 2017 |
| Tumour‐suppressive effects of curcumin analogs CCA‐1.1 and pentagamavunone‐1 in colon cancer: in vivo and in vitro studies F Wulandari, M Ikawati, S Widyarini, M Kirihata, D Novitasari, J Kato, ... Journal of Advanced Pharmaceutical Technology & Research 14 (4), 317-324, 2023 | 3 | 2023 |
| PGV-1 permanently arrests HepG2 cells in M phase and inhibits liver carcinogenesis in DMH-induced rats D Novitasari, J Kato, DDP Putri, F Wulandari, S Widyarini, UM Zulfin, ... Journal of Applied Pharmaceutical Science 13 (8), 204-211, 2023 | 3 | 2023 |
| Curcumin analogs PGV-1 and CCA-1.1 induce cell cycle arrest in human hepatocellular carcinoma cells with overexpressed MYCN M Moordiani, D Novitasari, RA Susidarti, J Kato, E Meiyanto The Indonesian Biomedical Journal 15 (2), 141-9, 2023 | 3 | 2023 |
| The evaluation of cytotoxic properties from CCB-2 sugar complexes against TNBC and non-TNBC cells RI Jenie, RY Utomo, RA Susidarti, D Novitasari, M Kirihata, E Meiyanto Asian Pacific Journal of Cancer Prevention: APJCP 22 (1), 151, 2021 | 3 | 2021 |
| Network pharmacological analysis identifies the curcumin analog CCA-1.1 targeting mitosis regulatory process in HER2-positive breast cancer D Novitasari, RI Jenie, J Kato, E Meiyanto Indonesian Journal of Pharmacy, 2023 | 2 | 2023 |
